Related Experiment Video
Updated: May 22, 2026
06:14
The Micronucleus Assay on Cryopreserved Whole Blood
Published on: February 23, 2024
Micronuclei in lymphocytes from currently active uranium miners
Friedo Zölzer1, Zdeněk Hon, Zuzana Freitinger Skalická
1Department of Radiology and Toxicology, Faculty of Health and Social Studies, University of South Bohemia in České Budějovice, České Budějovice, Czech Republic. zoelzer@zsf.jcu.cz
Radiation and Environmental Biophysics
|May 25, 2012
Summary
Micronuclei in lymphocytes indicate past radiation exposure in uranium miners. The micronucleus-centromere test shows higher frequencies in miners, correlating with their radiation dose.
Area of Science:
- Radiation Biology
- Biomonitoring
- Occupational Health
Background:
- Micronuclei serve as biomarkers for radiation exposure.
- Limited research exists on micronuclei in uranium miners.
- Uranium mining poses occupational radiation risks.
Purpose of the Study:
- To assess micronuclei frequencies in lymphocytes of current uranium miners.
- To evaluate the utility of the micronucleus-centromere test for radiation dose assessment in this cohort.
- To correlate micronuclei biomarkers with cumulative radiation doses in uranium miners.
Main Methods:
- A modified micronucleus-centromere test was employed.
- Lymphocytes from uranium miners and unexposed individuals were analyzed.
- Micronuclei were quantified for frequency and centromere presence (indicating chromosome fragments vs. whole chromosomes).
Main Results:
- Miners exhibited significantly higher frequencies of micronucleus-containing lymphocytes compared to controls.
- A significantly higher percentage of micronuclei lacking centromeres was observed in miners.
- Significant correlations were found between micronuclei parameters and 'retrievable' radiation dose, with dose doubling at ~35 mSv.
Conclusions:
- The micronucleus-centromere test is effective for assessing past radiation exposure in uranium miners.
- While not suitable for individual dosimetry, the method can monitor group doses below 100 mSv.
- This study validates the use of micronuclei as a biomarker in the specific context of uranium mining.
Related Concept Videos
01:25Microbial Bioremediation of Uranium
Microorganisms play a critical role in the transformation and immobilization of uranium in contaminated environments through four main pathways: bioreduction, biosorption, bioaccumulation, and biomineralization. These mechanisms reduce uranium’s toxicity and prevent its migration through groundwater systems, offering sustainable approaches for in situ bioremediation.Bioreduction of UraniumBioreduction is driven by anaerobic bacteria such as certain strains of Geobacter and Shewanella, which use...
03:20Nuclear Transmutation
Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed protons being...
02:55The Nucleolus
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...